Cargando…
Expert committee to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs-comments
All is not well with the clinical research industry. Instances of scientific misconduct by investigators, cutting corners by sponsors, irregularities by regulators, have brought a bad name to the industry. These however form a small part of the clinical research done in this country. The US FDA has...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073545/ https://www.ncbi.nlm.nih.gov/pubmed/24987579 http://dx.doi.org/10.4103/2229-3485.134304 |